AU2002308460A1 - The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification - Google Patents
The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modificationInfo
- Publication number
- AU2002308460A1 AU2002308460A1 AU2002308460A AU2002308460A AU2002308460A1 AU 2002308460 A1 AU2002308460 A1 AU 2002308460A1 AU 2002308460 A AU2002308460 A AU 2002308460A AU 2002308460 A AU2002308460 A AU 2002308460A AU 2002308460 A1 AU2002308460 A1 AU 2002308460A1
- Authority
- AU
- Australia
- Prior art keywords
- rptp
- effect
- receptor protein
- protein tyrosine
- tyrosine phosphatase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03048—Protein-tyrosine-phosphatase (3.1.3.48)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Environmental Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Biodiversity & Conservation Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28316201P | 2001-04-12 | 2001-04-12 | |
US60/283,162 | 2001-04-12 | ||
PCT/CA2002/000541 WO2002083182A2 (en) | 2001-04-12 | 2002-04-12 | The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002308460A1 true AU2002308460A1 (en) | 2002-10-28 |
Family
ID=23084799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002308460A Abandoned AU2002308460A1 (en) | 2001-04-12 | 2002-04-12 | The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002308460A1 (en) |
WO (1) | WO2002083182A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002060471A2 (en) * | 2001-01-30 | 2002-08-08 | Ich Productions Limited | Ligands for receptor-like protein tyrosine phosphatases |
WO2007041317A2 (en) * | 2005-09-29 | 2007-04-12 | Viral Logic Systems Technology Corp. | Immunomodulatory compositions and uses therefor |
WO2011022462A2 (en) * | 2009-08-18 | 2011-02-24 | President And Fellows Of Harvard College | Neural regeneration |
AU2012219323A1 (en) | 2011-02-18 | 2013-09-05 | President And Fellows Of Harvard College | Molecular switch for neuronal outgrowth |
US10729777B2 (en) | 2012-04-09 | 2020-08-04 | Case Western Reserve University | Compositions and methods for inhibiting the activity of LAR family phosphatases |
US10206967B2 (en) | 2012-04-09 | 2019-02-19 | Case Western Reserve University | Compositions and methods for treating heart disease and/or injury |
US10786541B2 (en) | 2012-04-09 | 2020-09-29 | Case Western Reserve University | Compositions and methods for treating heart disease and/or injury |
EP2841086B1 (en) * | 2012-04-09 | 2018-09-26 | Case Western Reserve University | Compositions for use in treating neural injury by inhibiting the activity of lar family phosphatases |
US10258672B2 (en) | 2014-10-09 | 2019-04-16 | Case Western Reserve University | Compositions and methods of treating root avulsion injury |
JP2020514394A (en) * | 2017-03-24 | 2020-05-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Proteoglycan irregularity in abnormal fibroblasts and therapies based on it |
US20200093890A1 (en) * | 2017-06-05 | 2020-03-26 | Case Western Reserve University | Compositions and methods for treating alzheimer's disease |
AU2019334965B2 (en) | 2018-09-05 | 2025-01-23 | Case Western Reserve University | Methods and compositions for inducing neural plasticity |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0721352A4 (en) * | 1993-10-01 | 1998-07-01 | Univ New York | Novel receptor-type phosphotyrosine phosphatase-sigma |
-
2002
- 2002-04-12 AU AU2002308460A patent/AU2002308460A1/en not_active Abandoned
- 2002-04-12 WO PCT/CA2002/000541 patent/WO2002083182A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002083182A2 (en) | 2002-10-24 |
WO2002083182A3 (en) | 2003-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002098898A3 (en) | FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU7687098A (en) | Systems and methods for modifying behavioral disorders | |
AU2001288628A1 (en) | Method and reagents for treatment of skin disorders by modulating the notch pathway | |
AU2002305793A1 (en) | Database access bridge system and process | |
AU2002308460A1 (en) | The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification | |
AU2653199A (en) | Pseudospontaneous neural stimulation system and method | |
WO2002099040A3 (en) | Igs as modifiers of the p53 pathway and methods of use | |
AU3709297A (en) | Fingerprint collation | |
AU6259998A (en) | Isolated p27 protein and methods for its production and use | |
ZA961481B (en) | Isolated nonapeptides presented by hla molecules and uses thereof | |
AU1251499A (en) | (-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders | |
AU3549697A (en) | Extracting particles produced by the treating of human or animal nails | |
AU5044298A (en) | Neuron and neural tumour growth regulatory system, antibodies thereto and uses thereof | |
HUP0004369A3 (en) | The use of substituted aminomethyl chroman derivatives for prevent neural degeneration and promote neural regeneration | |
AU2002310372A1 (en) | Pattern-recognition artificial neural with expert system | |
AU6550894A (en) | Human serotonin receptors, dna encoding the receptors, and uses thereof | |
AU7740900A (en) | Protein fingerprint system and related methods | |
AU1382099A (en) | Human phospholipase a2 protein and dna encoding it | |
AU4158797A (en) | Screening assay for the identification of agents which alter expression of pth-rp | |
FR2767943B1 (en) | CLASSIFICATION APPARATUS USING A COMBINATION OF STATISTICAL METHODS AND NEURAL NETWORKS, IN PARTICULAR FOR THE RECOGNITION OF ODORS | |
AU2002304931A1 (en) | Methods for treating disorders of the nervous and reproductive systems | |
AU3241895A (en) | Apoptosis related protein bcl-y, and methods of use thereof | |
WO1999009182A3 (en) | Rab proteins | |
NO994526L (en) | Procedure for stimulation of neural regeneration | |
AUPN115095A0 (en) | Analysis of and compositions and methods for the treatment of disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |